Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Imaging lens
Interface circuit and interface system
Humidity indicator and method for fabricating the same
System and method for multi-tiered meta-data caching and distribution in a clustered computer environment
Semiconductor apparatus
Method and system for coding an information signal using closed loop adaptive bit allocation
Modular microscope construction
  Randomly Featured Patents
Steam generating apparatus for skin care
45 degree masonry unit
Reinforced porous spinal implants
Overt comfort system
In-situ real-time monitoring technique and apparatus for endpoint detection of thin films during chemical/mechanical polishing planarization
Analgesic mixture of nalbuphine and flurbiprofen
Thermosetting resin composition comprising an aromatic amine
ESD protection devices and methods for reducing trigger voltage
Projection type liquid crystal display unit
Flame retardant resinous compositions and process